# A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

> **NCT05657743** · NA · RECRUITING · sponsor: **Alpha Tau Medical LTD.** · enrollment: 15 (estimated)

## Conditions studied

- Pancreatic Cancer
- Unresectable Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **DEVICE:** Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

## Key facts

- **NCT ID:** NCT05657743
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-16
- **Primary completion:** 2026-11
- **Final completion:** 2027-11
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05657743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05657743, "A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT05657743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*